Certain Omega-3 Extracts From Marine or Aquatic Biomass and Products Containing the Same; Commission Determination Not To Review an Initial Determination Granting a Joint Motion To Terminate the Investigation With Respect to Respondents Aker Biomarine as, Aker Biomarine Antarctic as, and Aker Biomarine Antarctic USA, Inc. on the Basis of a Settlement Agreement, 3623 [2014-01100]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 14 / Wednesday, January 22, 2014 / Notices
The Commission completed and filed
its determination in these reviews on
January 15, 2014. The views of the
Commission are contained in USITC
Publication 4445 (January 2014),
entitled Hot-Rolled Steel Products from
China, India, Indonesia, Taiwan,
Thailand, and Ukraine (Inv. Nos. 701–
TA–405, 406, & 408 and 731–TA–899–
901 & 906–908 (Second Review)).
By order of the Commission.
Issued: January 16, 2014.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2014–01169 Filed 1–21–14; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–877]
Certain Omega-3 Extracts From Marine
or Aquatic Biomass and Products
Containing the Same; Commission
Determination Not To Review an Initial
Determination Granting a Joint Motion
To Terminate the Investigation With
Respect to Respondents Aker
Biomarine as, Aker Biomarine
Antarctic as, and Aker Biomarine
Antarctic USA, Inc. on the Basis of a
Settlement Agreement
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined not to
review an initial determination (‘‘ID’’)
(Order No. 40) of the presiding
administrative law judge (‘‘ALJ’’)
granting a joint motion to terminate the
investigation with respect to
respondents Aker Biomarine AS, Aker
Biomarine Antarctic AS, and Aker
Biomarine Antarctic USA, Inc. on the
basis of a settlement agreement in the
above-captioned investigation.
FOR FURTHER INFORMATION CONTACT:
James A. Worth, Office of the General
Counsel, U.S. International Trade
Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202)
205–3065. Copies of non-confidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW., Washington, DC 20436,
telephone (202) 205–2000. General
information concerning the Commission
may also be obtained by accessing its
Internet server (https://www.usitc.gov).
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:00 Jan 21, 2014
Jkt 232001
The public record for this investigation
may be viewed on the Commission’s
electronic docket (EDIS) at https://
edis.usitc.gov. Hearing-impaired
persons are advised that information on
this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on April 17, 2013, based on a complaint
filed on January 29, 2013, as amended
on March 21, 2013, and supplemented
on April 1, 2013, on behalf of Neptune
Technologies & Bioressources Inc. of
´
Laval, Quebec, Canada and Acasti
´
Pharma Inc., also of Laval, Quebec,
Canada (collectively, ‘‘Complainants’’).
78 FR 22898–99 (April 17, 2013). The
amended complaint alleged violations
of Section 337 of the Tariff Act of 1930,
as amended, 19 U.S.C. 1337, in the sale
for importation, importation, or sale
within the United States after
importation of certain omega-3 extracts
from marine or aquatic biomass and
products containing the same by reason
of infringement of one or more of claims
1–46 and 94 of U.S. Patent No.
8,278,351 and claim 1 of the U.S. Patent
No. 8,383,675. The Commission’s notice
of investigation named as respondents
Aker BioMarine AS of Oslo, Norway;
Aker BioMarine Antarctic USA Inc. of
Issaquah, Washington; Aker BioMarine
Antarctic AS of Stamsund, Norway;
Enzymotec Limited of Industrial Zone
K’far Baruch, Israel; Enzymotec USA,
Inc. of Morristown, New Jersey;
˚
Olympic Seafood AS of Fosnavag,
Norway; Olympic Biotec Ltd. of New
Zealand; Avoca, Inc. of Merry Hill,
North Carolina; Rimfrost USA, LLC of
Merry Hill, North Carolina; and
Bioriginal Food & Science Corp. of
Saskatoon, Saskatchewan, Canada.
On December 13, 2013, Complainants
and respondents Aker Biomarine AS,
Aker Biomarine Antarctic AS, and Aker
Biomarine Antarctic USA, Inc.
(collectively, ‘‘the Aker Respondents’’)
filed an amended joint motion to
terminate the investigation with respect
to the Aker Respondents on the basis of
a settlement agreement. The motion
stated that no other respondent
opposed. On December 16, 2013, the
Commission investigative attorney filed
a response in support of the motion. On
December 17, 2013, the ALJ issued the
subject ID (Order No. 40), granting
Complainants’ motion.
After considering the ID and the
relevant portions of the record, the
Commission has determined not to
review the ID. The Commission agrees
with the ALJ that the amended joint
motion for termination complies with
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
3623
the requirements of Commission rule
210.21 and that the settlement does not
adversely affect the public health and
welfare, competitive conditions in the
U.S. economy, the production of like or
directly competitive articles in the
United States, and U.S. consumers.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
Dated: January 15, 2014.
By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2014–01100 Filed 1–21–14; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–452 and 731–
TA–1129–1130 (Review)]
Raw Flexible Magnets From China and
Taiwan
Determination
On the basis of the record 1 developed
in the subject five-year reviews, the
United States International Trade
Commission (Commission) determines,
pursuant to section 751(c) of the Tariff
Act of 1930 (19 U.S.C. 1675(c)), that
revocation of the countervailing duty
order on raw flexible magnets from
China and the antidumping duty orders
on raw flexible magnets from China and
Taiwan would be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
The Commission instituted these
reviews on August 1, 2013 (78 FR
46604) and determined on November
20, 2013 that it would conduct
expedited reviews (78 FR 73561,
December 6, 2013).
The Commission completed and filed
its determination in these reviews on
January 15, 2014. The views of the
Commission are contained in USITC
Publication 4449 (January 2014),
entitled Raw Flexible Magnets from
China and Taiwan: Investigation Nos.
701–TA–452 and 731–TA–1129–1130
(Review).
Dated: January 15, 2014.
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 79, Number 14 (Wednesday, January 22, 2014)]
[Notices]
[Page 3623]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01100]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-877]
Certain Omega-3 Extracts From Marine or Aquatic Biomass and
Products Containing the Same; Commission Determination Not To Review an
Initial Determination Granting a Joint Motion To Terminate the
Investigation With Respect to Respondents Aker Biomarine as, Aker
Biomarine Antarctic as, and Aker Biomarine Antarctic USA, Inc. on the
Basis of a Settlement Agreement
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has determined not to review an initial determination
(``ID'') (Order No. 40) of the presiding administrative law judge
(``ALJ'') granting a joint motion to terminate the investigation with
respect to respondents Aker Biomarine AS, Aker Biomarine Antarctic AS,
and Aker Biomarine Antarctic USA, Inc. on the basis of a settlement
agreement in the above-captioned investigation.
FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General
Counsel, U.S. International Trade Commission, 500 E Street SW.,
Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are
or will be available for inspection during official business hours
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street SW., Washington, DC 20436,
telephone (202) 205-2000. General information concerning the Commission
may also be obtained by accessing its Internet server (https://www.usitc.gov). The public record for this investigation may be viewed
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov.
Hearing-impaired persons are advised that information on this matter
can be obtained by contacting the Commission's TDD terminal on (202)
205-1810.
SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
on April 17, 2013, based on a complaint filed on January 29, 2013, as
amended on March 21, 2013, and supplemented on April 1, 2013, on behalf
of Neptune Technologies & Bioressources Inc. of Laval, Qu[eacute]bec,
Canada and Acasti Pharma Inc., also of Laval, Qu[eacute]bec, Canada
(collectively, ``Complainants''). 78 FR 22898-99 (April 17, 2013). The
amended complaint alleged violations of Section 337 of the Tariff Act
of 1930, as amended, 19 U.S.C. 1337, in the sale for importation,
importation, or sale within the United States after importation of
certain omega-3 extracts from marine or aquatic biomass and products
containing the same by reason of infringement of one or more of claims
1-46 and 94 of U.S. Patent No. 8,278,351 and claim 1 of the U.S. Patent
No. 8,383,675. The Commission's notice of investigation named as
respondents Aker BioMarine AS of Oslo, Norway; Aker BioMarine Antarctic
USA Inc. of Issaquah, Washington; Aker BioMarine Antarctic AS of
Stamsund, Norway; Enzymotec Limited of Industrial Zone K'far Baruch,
Israel; Enzymotec USA, Inc. of Morristown, New Jersey; Olympic Seafood
AS of Fosnav[aring]g, Norway; Olympic Biotec Ltd. of New Zealand;
Avoca, Inc. of Merry Hill, North Carolina; Rimfrost USA, LLC of Merry
Hill, North Carolina; and Bioriginal Food & Science Corp. of Saskatoon,
Saskatchewan, Canada.
On December 13, 2013, Complainants and respondents Aker Biomarine
AS, Aker Biomarine Antarctic AS, and Aker Biomarine Antarctic USA, Inc.
(collectively, ``the Aker Respondents'') filed an amended joint motion
to terminate the investigation with respect to the Aker Respondents on
the basis of a settlement agreement. The motion stated that no other
respondent opposed. On December 16, 2013, the Commission investigative
attorney filed a response in support of the motion. On December 17,
2013, the ALJ issued the subject ID (Order No. 40), granting
Complainants' motion.
After considering the ID and the relevant portions of the record,
the Commission has determined not to review the ID. The Commission
agrees with the ALJ that the amended joint motion for termination
complies with the requirements of Commission rule 210.21 and that the
settlement does not adversely affect the public health and welfare,
competitive conditions in the U.S. economy, the production of like or
directly competitive articles in the United States, and U.S. consumers.
The authority for the Commission's determination is contained in
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
part 210).
Dated: January 15, 2014.
By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2014-01100 Filed 1-21-14; 8:45 am]
BILLING CODE 7020-02-P
